The Associated Press gives a rundown of what little is known about He Jiankui and the twin girls since his announcement last year that he had edited their genomes as embryos.
In Genome Biology this week: analysis of gut microbiomes from the Hispanic Community Health Study/Study of Latinos, collection of patient-derived tumor cells from gynecological cancers, and more.
Carnegie Mellon University and Elsevier make a "read-and-publish" deal, Inside Higher Ed reports.
According to the Associated Press, police in Germany are seeking DNA samples from 900 men to tackle a cold case.
Forbes reports on firms using artificial intelligence to diagnose rare genetic diseases.
In PNAS this week: genomic analysis of the venomous Hispaniolan solenodon, Epstein-Barr virus amplification in replication compartments, and more.
In PLOS this week: genome-wide association study of epigenetic age acceleration, antimicrobial resistance genes found in organic egg farm samples, and more.
Retraction Watch reports that the National Institutes of Health plans to remove conditions it placed on Duke University in 2018 following instances of research misconduct.
New Scientist reports that embryo screening from the firm Genomic Prediction has been used in at least one pregnancy.
A genome-wide association study links more than 40 genes associated with being left handed, Psychology Today reports.
A bioethicist from Abertay University uses a utilitarian approach to justify genetically modifying the human germline, the BBC reports.
The General Data Protection Regulation has slowed some data sharing with non-European researchers as they find ways to comply with the law, ScienceInsider reports.
The US has upgraded its network of public health labs to provide whole-genome sequencing to track antibiotic-resistant bacteria, Quartz reports.
In Science this week: approach to visualize 3D genome structure in single cells, RNA interference knockdown screens to examine genetic origins of beetle horns and insect wings, and more.
The US Food and Drug Administration has approved an RNA interference drug to treat acute hepatic porphyria.
Stephen Hahn, the nominee to lead the US Food and Drug Administration, underwent a Senate confirmation hearing yesterday, the Washington Post reports.
Gizmodo looks over the past decade of consumer DNA testing to find the field to be lacking.
In Nature this week: native RNA sequencing and analysis of a human poly(A) transcriptome, nanopore sequencing-based method to analyze short tandem repeat expansions, and more.
NPR reports that the patient who underwent a CRISPR-based treatment for sickle cell disease is doing well.
Resistance to ash dieback disease among some UK ash trees appears polygenic, the Independent reports.
In Nucleic Acids Research this week: sequencing strategy for flash-frozen brain tissue bank samples, new version of ChlamDB, and more.
A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.
The president of Nankai University is embroiled in a data manipulation scandal, the South China Morning Post reports.
LiveScience reports that a novel mutation in the LPL gene was uncovered in three siblings with very high triglyceride levels.
In PNAS this week: cytotoxic CD4 T cell signature in supercentenarians, evolutionary history of beetles, and more.
The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.
60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.
In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.
GenomeWeb reports that Veritas Genetics is suspending its US operations.